Loading…
T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma
T2-weighted MRI shows potential in early posttreatment assessment of the primary tumor. Residual masses composed entirely of low T2-signal scar tissue suggest local control and those ≥1 cm of similar signal to untreated tumor suggest local failure. The purpose of this study was to investigate the di...
Saved in:
Published in: | American journal of neuroradiology : AJNR 2013-06, Vol.34 (6), p.1237-1241 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c411t-1cd99ceb9640d5fa4889cd64cb8ab8a843ca65eacf82f3320b61f8bbd45404bc3 |
---|---|
cites | cdi_FETCH-LOGICAL-c411t-1cd99ceb9640d5fa4889cd64cb8ab8a843ca65eacf82f3320b61f8bbd45404bc3 |
container_end_page | 1241 |
container_issue | 6 |
container_start_page | 1237 |
container_title | American journal of neuroradiology : AJNR |
container_volume | 34 |
creator | King, A D Keung, C K Yu, K-H Mo, F K F Bhatia, K S Yeung, D K W Tse, G M K Vlantis, A C Ahuja, A T |
description | T2-weighted MRI shows potential in early posttreatment assessment of the primary tumor. Residual masses composed entirely of low T2-signal scar tissue suggest local control and those ≥1 cm of similar signal to untreated tumor suggest local failure. The purpose of this study was to investigate the diagnostic accuracy of T2-weighted MR imaging early after chemoradiotherapy for identifying primary tumor treatment failure in squamous cell carcinoma of the head and neck.
At 6 weeks after treatment, T2-weighted MR images of 37 primary tumors in 37 patients were assessed. Residual masses were divided into 3 patterns: pattern 1 = scar tissue only (flat-edged/retracted mass of low T2 signal intensity); pattern 2 = mass without features described in pattern 1 or 3; and pattern 3 = any pattern that included an expansile mass ≥1 cm of intermediate T2 signal intensity (similar grade of signal intensity to the untreated tumor). T2 patterns were analyzed for local outcome (Fisher exact test) and time to local failure (univariate and multivariate analysis of T2 pattern, age, T stage, and tumor size by use of the Cox regression model).
Residual masses after treatment were present in 34 (92%) of 37 patients. Local failures occurred in residual masses with pattern 1 in 0 (0%) of 14 patients; pattern 2 in 6 (55%) of 11 patients; and pattern 3 in 9 (100%) of 9 patients. Significant associations were found between local control and pattern 1 (P = |
doi_str_mv | 10.3174/ajnr.A3378 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7964595</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1367877893</sourcerecordid><originalsourceid>FETCH-LOGICAL-c411t-1cd99ceb9640d5fa4889cd64cb8ab8a843ca65eacf82f3320b61f8bbd45404bc3</originalsourceid><addsrcrecordid>eNqFkU-LFDEQxYMo7rh68QNIjiL0mnSS7uQiLIv_YEWQFbyF6nT1dNbuZDZJrwz44e1x1kVPQkEd6ser93iEPOfsTPBWvobrkM7OhWj1A7LhRjSVUebbQ7Jh3Kiq4UyfkCc5XzPGlGnrx-SkFoI1jNcb8vOqrn6g344Fe_rpC_UzbH3YUoQ07SkMBRN1I84xQe9jGTHBbk9LpHgL0wIFaUkIZcZQaMK8iyEj9YGOCD2F0NOA7jvNNwvMccnU4TRRB8n5EGd4Sh4NMGV8drdPydd3b68uPlSXn99_vDi_rJzkvFTc9cY47EwjWa8GkFob1zfSdRrW0VI4aBSCG3Q9CFGzruGD7rpeKslk58QpeXPU3S3djL1bzSaY7C6tadPeRvD230vwo93GW9uuL5VRq8DLO4EUbxbMxc4-H7JAwDWW5UrxppbaiP-joml12x7RV0fUpZhzwuHeEWf20Kw9NGt_N7vCL_7OcI_-qVL8Alekoyk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1367877893</pqid></control><display><type>article</type><title>T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma</title><source>NCBI_PubMed Central(免费)</source><creator>King, A D ; Keung, C K ; Yu, K-H ; Mo, F K F ; Bhatia, K S ; Yeung, D K W ; Tse, G M K ; Vlantis, A C ; Ahuja, A T</creator><creatorcontrib>King, A D ; Keung, C K ; Yu, K-H ; Mo, F K F ; Bhatia, K S ; Yeung, D K W ; Tse, G M K ; Vlantis, A C ; Ahuja, A T</creatorcontrib><description>T2-weighted MRI shows potential in early posttreatment assessment of the primary tumor. Residual masses composed entirely of low T2-signal scar tissue suggest local control and those ≥1 cm of similar signal to untreated tumor suggest local failure. The purpose of this study was to investigate the diagnostic accuracy of T2-weighted MR imaging early after chemoradiotherapy for identifying primary tumor treatment failure in squamous cell carcinoma of the head and neck.
At 6 weeks after treatment, T2-weighted MR images of 37 primary tumors in 37 patients were assessed. Residual masses were divided into 3 patterns: pattern 1 = scar tissue only (flat-edged/retracted mass of low T2 signal intensity); pattern 2 = mass without features described in pattern 1 or 3; and pattern 3 = any pattern that included an expansile mass ≥1 cm of intermediate T2 signal intensity (similar grade of signal intensity to the untreated tumor). T2 patterns were analyzed for local outcome (Fisher exact test) and time to local failure (univariate and multivariate analysis of T2 pattern, age, T stage, and tumor size by use of the Cox regression model).
Residual masses after treatment were present in 34 (92%) of 37 patients. Local failures occurred in residual masses with pattern 1 in 0 (0%) of 14 patients; pattern 2 in 6 (55%) of 11 patients; and pattern 3 in 9 (100%) of 9 patients. Significant associations were found between local control and pattern 1 (P = <.0001; sensitivity, 74%; specificity, 100%; PPV, 100%; NPV, 75%; accuracy, 85%), and between local failure and pattern 3 (P = <.0001; sensitivity, 60%; specificity, 100%; PPV, 100%; NPV, 76%; accuracy, 82%). Pattern 2 showed no significant associations with local outcome. Univariate analysis of time to local failure showed that the T2 pattern was significant (P < .0001) and remained significant on multivariate analysis.
T2-weighted MR imaging is a potential tool for early posttreatment assessment of primary HNSCC treatment response. Awareness of correlation of the T2 pattern of any residual mass with treatment outcome at the primary site may contribute to patient treatment.</description><identifier>ISSN: 0195-6108</identifier><identifier>EISSN: 1936-959X</identifier><identifier>DOI: 10.3174/ajnr.A3378</identifier><identifier>PMID: 23306012</identifier><language>eng</language><publisher>United States: American Society of Neuroradiology</publisher><subject>Aged ; Carcinoma, Squamous Cell - pathology ; Carcinoma, Squamous Cell - therapy ; Chemoradiotherapy ; Diffusion Magnetic Resonance Imaging - methods ; Diffusion Magnetic Resonance Imaging - standards ; Drug Monitoring - methods ; Female ; Head & Neck ; Head and Neck Neoplasms - pathology ; Head and Neck Neoplasms - therapy ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoplasm, Residual - pathology ; Neoplasm, Residual - therapy ; Nuclear polyhedrosis virus ; Predictive Value of Tests ; Reproducibility of Results ; Retrospective Studies ; Sensitivity and Specificity ; Treatment Failure</subject><ispartof>American journal of neuroradiology : AJNR, 2013-06, Vol.34 (6), p.1237-1241</ispartof><rights>2013 by American Journal of Neuroradiology 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c411t-1cd99ceb9640d5fa4889cd64cb8ab8a843ca65eacf82f3320b61f8bbd45404bc3</citedby><cites>FETCH-LOGICAL-c411t-1cd99ceb9640d5fa4889cd64cb8ab8a843ca65eacf82f3320b61f8bbd45404bc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7964595/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7964595/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23306012$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>King, A D</creatorcontrib><creatorcontrib>Keung, C K</creatorcontrib><creatorcontrib>Yu, K-H</creatorcontrib><creatorcontrib>Mo, F K F</creatorcontrib><creatorcontrib>Bhatia, K S</creatorcontrib><creatorcontrib>Yeung, D K W</creatorcontrib><creatorcontrib>Tse, G M K</creatorcontrib><creatorcontrib>Vlantis, A C</creatorcontrib><creatorcontrib>Ahuja, A T</creatorcontrib><title>T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma</title><title>American journal of neuroradiology : AJNR</title><addtitle>AJNR Am J Neuroradiol</addtitle><description>T2-weighted MRI shows potential in early posttreatment assessment of the primary tumor. Residual masses composed entirely of low T2-signal scar tissue suggest local control and those ≥1 cm of similar signal to untreated tumor suggest local failure. The purpose of this study was to investigate the diagnostic accuracy of T2-weighted MR imaging early after chemoradiotherapy for identifying primary tumor treatment failure in squamous cell carcinoma of the head and neck.
At 6 weeks after treatment, T2-weighted MR images of 37 primary tumors in 37 patients were assessed. Residual masses were divided into 3 patterns: pattern 1 = scar tissue only (flat-edged/retracted mass of low T2 signal intensity); pattern 2 = mass without features described in pattern 1 or 3; and pattern 3 = any pattern that included an expansile mass ≥1 cm of intermediate T2 signal intensity (similar grade of signal intensity to the untreated tumor). T2 patterns were analyzed for local outcome (Fisher exact test) and time to local failure (univariate and multivariate analysis of T2 pattern, age, T stage, and tumor size by use of the Cox regression model).
Residual masses after treatment were present in 34 (92%) of 37 patients. Local failures occurred in residual masses with pattern 1 in 0 (0%) of 14 patients; pattern 2 in 6 (55%) of 11 patients; and pattern 3 in 9 (100%) of 9 patients. Significant associations were found between local control and pattern 1 (P = <.0001; sensitivity, 74%; specificity, 100%; PPV, 100%; NPV, 75%; accuracy, 85%), and between local failure and pattern 3 (P = <.0001; sensitivity, 60%; specificity, 100%; PPV, 100%; NPV, 76%; accuracy, 82%). Pattern 2 showed no significant associations with local outcome. Univariate analysis of time to local failure showed that the T2 pattern was significant (P < .0001) and remained significant on multivariate analysis.
T2-weighted MR imaging is a potential tool for early posttreatment assessment of primary HNSCC treatment response. Awareness of correlation of the T2 pattern of any residual mass with treatment outcome at the primary site may contribute to patient treatment.</description><subject>Aged</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Carcinoma, Squamous Cell - therapy</subject><subject>Chemoradiotherapy</subject><subject>Diffusion Magnetic Resonance Imaging - methods</subject><subject>Diffusion Magnetic Resonance Imaging - standards</subject><subject>Drug Monitoring - methods</subject><subject>Female</subject><subject>Head & Neck</subject><subject>Head and Neck Neoplasms - pathology</subject><subject>Head and Neck Neoplasms - therapy</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoplasm, Residual - pathology</subject><subject>Neoplasm, Residual - therapy</subject><subject>Nuclear polyhedrosis virus</subject><subject>Predictive Value of Tests</subject><subject>Reproducibility of Results</subject><subject>Retrospective Studies</subject><subject>Sensitivity and Specificity</subject><subject>Treatment Failure</subject><issn>0195-6108</issn><issn>1936-959X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqFkU-LFDEQxYMo7rh68QNIjiL0mnSS7uQiLIv_YEWQFbyF6nT1dNbuZDZJrwz44e1x1kVPQkEd6ser93iEPOfsTPBWvobrkM7OhWj1A7LhRjSVUebbQ7Jh3Kiq4UyfkCc5XzPGlGnrx-SkFoI1jNcb8vOqrn6g344Fe_rpC_UzbH3YUoQ07SkMBRN1I84xQe9jGTHBbk9LpHgL0wIFaUkIZcZQaMK8iyEj9YGOCD2F0NOA7jvNNwvMccnU4TRRB8n5EGd4Sh4NMGV8drdPydd3b68uPlSXn99_vDi_rJzkvFTc9cY47EwjWa8GkFob1zfSdRrW0VI4aBSCG3Q9CFGzruGD7rpeKslk58QpeXPU3S3djL1bzSaY7C6tadPeRvD230vwo93GW9uuL5VRq8DLO4EUbxbMxc4-H7JAwDWW5UrxppbaiP-joml12x7RV0fUpZhzwuHeEWf20Kw9NGt_N7vCL_7OcI_-qVL8Alekoyk</recordid><startdate>201306</startdate><enddate>201306</enddate><creator>King, A D</creator><creator>Keung, C K</creator><creator>Yu, K-H</creator><creator>Mo, F K F</creator><creator>Bhatia, K S</creator><creator>Yeung, D K W</creator><creator>Tse, G M K</creator><creator>Vlantis, A C</creator><creator>Ahuja, A T</creator><general>American Society of Neuroradiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>201306</creationdate><title>T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma</title><author>King, A D ; Keung, C K ; Yu, K-H ; Mo, F K F ; Bhatia, K S ; Yeung, D K W ; Tse, G M K ; Vlantis, A C ; Ahuja, A T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c411t-1cd99ceb9640d5fa4889cd64cb8ab8a843ca65eacf82f3320b61f8bbd45404bc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Aged</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Carcinoma, Squamous Cell - therapy</topic><topic>Chemoradiotherapy</topic><topic>Diffusion Magnetic Resonance Imaging - methods</topic><topic>Diffusion Magnetic Resonance Imaging - standards</topic><topic>Drug Monitoring - methods</topic><topic>Female</topic><topic>Head & Neck</topic><topic>Head and Neck Neoplasms - pathology</topic><topic>Head and Neck Neoplasms - therapy</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoplasm, Residual - pathology</topic><topic>Neoplasm, Residual - therapy</topic><topic>Nuclear polyhedrosis virus</topic><topic>Predictive Value of Tests</topic><topic>Reproducibility of Results</topic><topic>Retrospective Studies</topic><topic>Sensitivity and Specificity</topic><topic>Treatment Failure</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>King, A D</creatorcontrib><creatorcontrib>Keung, C K</creatorcontrib><creatorcontrib>Yu, K-H</creatorcontrib><creatorcontrib>Mo, F K F</creatorcontrib><creatorcontrib>Bhatia, K S</creatorcontrib><creatorcontrib>Yeung, D K W</creatorcontrib><creatorcontrib>Tse, G M K</creatorcontrib><creatorcontrib>Vlantis, A C</creatorcontrib><creatorcontrib>Ahuja, A T</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of neuroradiology : AJNR</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>King, A D</au><au>Keung, C K</au><au>Yu, K-H</au><au>Mo, F K F</au><au>Bhatia, K S</au><au>Yeung, D K W</au><au>Tse, G M K</au><au>Vlantis, A C</au><au>Ahuja, A T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma</atitle><jtitle>American journal of neuroradiology : AJNR</jtitle><addtitle>AJNR Am J Neuroradiol</addtitle><date>2013-06</date><risdate>2013</risdate><volume>34</volume><issue>6</issue><spage>1237</spage><epage>1241</epage><pages>1237-1241</pages><issn>0195-6108</issn><eissn>1936-959X</eissn><abstract>T2-weighted MRI shows potential in early posttreatment assessment of the primary tumor. Residual masses composed entirely of low T2-signal scar tissue suggest local control and those ≥1 cm of similar signal to untreated tumor suggest local failure. The purpose of this study was to investigate the diagnostic accuracy of T2-weighted MR imaging early after chemoradiotherapy for identifying primary tumor treatment failure in squamous cell carcinoma of the head and neck.
At 6 weeks after treatment, T2-weighted MR images of 37 primary tumors in 37 patients were assessed. Residual masses were divided into 3 patterns: pattern 1 = scar tissue only (flat-edged/retracted mass of low T2 signal intensity); pattern 2 = mass without features described in pattern 1 or 3; and pattern 3 = any pattern that included an expansile mass ≥1 cm of intermediate T2 signal intensity (similar grade of signal intensity to the untreated tumor). T2 patterns were analyzed for local outcome (Fisher exact test) and time to local failure (univariate and multivariate analysis of T2 pattern, age, T stage, and tumor size by use of the Cox regression model).
Residual masses after treatment were present in 34 (92%) of 37 patients. Local failures occurred in residual masses with pattern 1 in 0 (0%) of 14 patients; pattern 2 in 6 (55%) of 11 patients; and pattern 3 in 9 (100%) of 9 patients. Significant associations were found between local control and pattern 1 (P = <.0001; sensitivity, 74%; specificity, 100%; PPV, 100%; NPV, 75%; accuracy, 85%), and between local failure and pattern 3 (P = <.0001; sensitivity, 60%; specificity, 100%; PPV, 100%; NPV, 76%; accuracy, 82%). Pattern 2 showed no significant associations with local outcome. Univariate analysis of time to local failure showed that the T2 pattern was significant (P < .0001) and remained significant on multivariate analysis.
T2-weighted MR imaging is a potential tool for early posttreatment assessment of primary HNSCC treatment response. Awareness of correlation of the T2 pattern of any residual mass with treatment outcome at the primary site may contribute to patient treatment.</abstract><cop>United States</cop><pub>American Society of Neuroradiology</pub><pmid>23306012</pmid><doi>10.3174/ajnr.A3378</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0195-6108 |
ispartof | American journal of neuroradiology : AJNR, 2013-06, Vol.34 (6), p.1237-1241 |
issn | 0195-6108 1936-959X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7964595 |
source | NCBI_PubMed Central(免费) |
subjects | Aged Carcinoma, Squamous Cell - pathology Carcinoma, Squamous Cell - therapy Chemoradiotherapy Diffusion Magnetic Resonance Imaging - methods Diffusion Magnetic Resonance Imaging - standards Drug Monitoring - methods Female Head & Neck Head and Neck Neoplasms - pathology Head and Neck Neoplasms - therapy Humans Kaplan-Meier Estimate Male Middle Aged Neoplasm, Residual - pathology Neoplasm, Residual - therapy Nuclear polyhedrosis virus Predictive Value of Tests Reproducibility of Results Retrospective Studies Sensitivity and Specificity Treatment Failure |
title | T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T14%3A16%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=T2-weighted%20MR%20imaging%20early%20after%20chemoradiotherapy%20to%20evaluate%20treatment%20response%20in%20head%20and%20neck%20squamous%20cell%20carcinoma&rft.jtitle=American%20journal%20of%20neuroradiology%20:%20AJNR&rft.au=King,%20A%20D&rft.date=2013-06&rft.volume=34&rft.issue=6&rft.spage=1237&rft.epage=1241&rft.pages=1237-1241&rft.issn=0195-6108&rft.eissn=1936-959X&rft_id=info:doi/10.3174/ajnr.A3378&rft_dat=%3Cproquest_pubme%3E1367877893%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c411t-1cd99ceb9640d5fa4889cd64cb8ab8a843ca65eacf82f3320b61f8bbd45404bc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1367877893&rft_id=info:pmid/23306012&rfr_iscdi=true |